Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the...
-
November 2025 Monthly Dividend of $0.12 Per Share of Common StockRMBS Portfolio Characteristics as of October 31, 2025Next Dividend Announcement Expected December 9, 2025 VERO BEACH, Fla., Nov. 12,...
-
NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Questex’s Hotel Management today announces winners of the annual “GMs to Watch” award, showcasing creative, resilient and dynamic leaders in the...
-
VERO BEACH, FL, Nov. 07, 2025 (GLOBE NEWSWIRE) -- VERO BEACH, FL - November 06, 2025 - - Lowery's Plumbing & Leak Detection is marking its third anniversary this month, reflecting on three...
-
VERO BEACH, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bimini Capital Management, Inc. (OTCQB:BMNM) ("Bimini” or the “Company”) today announced that Frank E. Jaumot has resigned as a director of the...
-
VERO BEACH, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bimini Capital Management, Inc. (OTCQB: BMNM), (“Bimini Capital,” “Bimini,” or the “Company”), today announced results of operations for the...
-
VERO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies and...
-
QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in Cash Represents a 139.7% premium to most recent Nasdaq closing price Transaction expected to close by the end of 2025 ...
-
Réponse immunitaire améliorée avec le candidat vaccin de deuxième génération Saint-Herblain (France), le 4 novembre 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans...
-
Immune response successfully improved with second generation vaccine candidate Saint-Herblain (France), November 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company,...